Table 2 Patient characteristics of LGSC compared with HGSC
Clinicopathologic features | LGSC | HGSC | P value | |||
|---|---|---|---|---|---|---|
Age median(range) | 54 | (27-77) | 56 | (36-77) | 0.075 | |
FIGO | I | 6 | 23.1% | 0 | 0.0% | 0.002 |
II | 0 | 0.0% | 2 | 3.8% | ||
III | 19 | 73.1% | 44 | 84.6% | ||
IV | 1 | 3.8% | 6 | 11.5% | ||
Family history | Yes | 4 | 15.4% | 12 | 23.1% | 0.557 |
No | 22 | 84.6% | 40 | 76.9% | ||
Cytoreduction | R0 | 13 | 50.0% | 16 | 30.8% | 0.25 |
0.1-1Â cm | 9 | 34.6% | 24 | 46.2% | ||
≥1 cm | 4 | 15.4% | 12 | 23.1% | ||
Chemosensitivity | Yes | 15 | 57.7% | 33 | 63.4% | 0.656 |
No | 8 | 30.8% | 16 | 30.8% | ||
NA | 3 | 11.5% | 3 | 5.8% | ||
ER | + | 21 | 80.8% | 36 | 70.6% | 0.417 |
- | 5 | 19.2% | 15 | 29.4% | ||
PR | + | 9 | 34.6% | 5 | 9.8% | 0.012 |
- | 17 | 65.4% | 46 | 90.2% | ||
AR | + | 14 | 53.8% | 17 | 33.3% | 0.089 |
- | 12 | 46.2% | 34 | 66.7% | ||
FSHR | + | 21 | 84.0% | 28 | 54.9% | 0.021 |
- | 4 | 16.0% | 23 | 45.1% | ||
LHR | + | 17 | 65.4% | 18 | 35.3% | 0.015 |
- | 9 | 34.6% | 33 | 64.7% | ||
GnRHR | + | 24 | 100.0% | 40 | 81.6% | 0.026 |
- | 0 | 0.0% | 9 | 18.4% | ||